The Hill22d
PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC
on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through vertical integration, industry dominance ...
A 22-year-old from Appleton died after his inhaler price skyrocketed. His parents are suing.
The parents of Cole Schmidtknecht are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the 22-year-old ...
PBMs Under Fire Again, But Despite Bipartisan Pressure Reforms May Be Elusive
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months critical of pharmacy benefit managers.
Kansas pharmacists are closing their doors as they seek a way to save their businesses struggling from PBM practices
Wednesday, 92 independent, mom-pop pharmacies across the state will close their doors for a day of advocacy in Topeka. It’s a ...
The Oklahoman13d
Only an act of Congress can stop pharmacy monopolies, Sen. Lankford says
“They don’t call it a monopoly, they call it vertical integration,” Lankford said. “They make money at every single stage.
Fierce Healthcare22d
FTC: Big 3 PBMs generated $7.3B from specialty generic drug markups
PBM-affiliated pharmacy dispensing revenue increased ... The FTC’s first interim report—which detailed the impacts of vertical integration and unfair contractual relationships—was more ...
Becker's Hospital Review23d
FTC finds top 3 PBMs inflated drug prices by $7.3B
According to the FTC's initial report from July 2024, the three largest PBMs handle 79% of U.S. prescriptions and have increased their control through further vertical integration with health ...
Modern Healthcare22d
Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC
High pharmaceutical costs and broader, bipartisan concerns about the effects of consolidation and vertical integration ... Ferguson has supported the agency’s PBM investigation.